Senate FDA User Fee Bill’s Mandatory Supplement Listing Provision Unites Industry In Opposition

Senate HELP Committee didn’t add amendments to user fee bill to protect confidential information and prevent FDA over-regulation in an MPL program, trade groups say. MPL proponents join opponents in saying language in S.4348 isn’t the answer.

• Source: Shutterstock (Shutterstock)

Legislation for mandatory product listing a Senate committee has passed isn’t what some dietary supplement industry stakeholders supported and expected, pushing them to partial agreement with others opposing the proposal but also any requirement to register all supplements with regulators.

A separate provision in the Food and Drug Administration user fee reauthorization bill the Senate Health, Education, Labor and Pension...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from International

More from Geography